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LETTERS TO THE EDITOR
Regarding “Surveillance of small aortic aneurysms
does not alter anatomic suitability for endovascular
repair”
In the article by Yau et al,1 the authors recently analyzed
changes in anatomical suitability for endovascular repair (EVAR)
occurring over time in small aortic aneurysms. The report focuses
on a largely debated issue. Two randomized trials (one American
and one European)2,3 are ongoing to find an answer as to whether
or not early endografting can have a better outcome in avoiding
adverse events and loss of suitability in patients with aneurysms less
than 5.5 cm.
Yau et al retrospectively reviewed the records of 54 patients at
a medium follow-up of 24 months and concluded that minor
changes occurred and did not affect EVAR suitability.
Unfortunately, only a small number of patients (54) were
included with a short follow-up (median 24 months, interquartile
range 15 to 36 months); reduced patients survival according to
KaplanMeyer estimates (78% at 30months and 61% at 50months)
further decreased the study population and the resulting number
of observations recorded. Furthermore, it should be noted that
25% of patients dropped out during the follow-up due to abdom-
inal aortic aneurysm (AAA) repair performed at another institu-
tion. Nevertheless, changes in aortic neck were detected in a
substantial percentage of cases. Aortic neck is the key point to
assess EVAR suitability and to ensure long-term success of en-
dografting.4-6 In the present study, the authors showed that me-
dian neck length decreased nearly 30% (from 26.5 to 20 mm; P 
.001) median neck diameter increased (from 23 to 24 mm; P
.02), and growth in median AAA diameter from 44.5 to 48.9
mmwas observed. All these relevant modifications seem to contra-
dict the conclusions by the authors that the observed changes did
not decrease the suitability for EVAR. Considering a larger study
group and a longer follow-up, if this trend is maintained, we may
expect more substantial modifications and a potential increased
risk of adverse events.
This study further confirms that growth rate and morpholog-
ical modifications in small AAA may be difficult to predict, com-
promising a safe repair at a later stage. The substantial uncertainty
whether surveillance is better than EVAR in small aneurysms still
remains. Significant answers could be obtained by the results of the
ongoing randomized trials.
Piergiorgio Cao, MD, FRCS, Paola De Rango, MD, Gianbattista
Parlani, MD, and Fabio Verzini, MD
Division of Vascular and Endovascular Surgery
University of Perugia
Ospedale S. Maria della Misericordia
Perugia, Italy
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Reply
We appreciate Dr Cao’s discerning comments and questions.
Although our study consisted of only 54 participants, it is likely the
largest cohort of its kind to longitudinally observe the natural
morphologic history of small aneurysm growth in the same pa-
tients over time.Most other studies compare different populations,
different aneurysm sizes, at different time points.1-3 As previously
mentioned, studying small aneurysm growth will always be hand-
icapped by attrition from surgery, rupture and death. More than
half of small aneurysm (45 to 49 mm) in the Aneurysm Detection
and Management (ADAM) study required surgery during a 2-year
period.4 No study can escape this reality.
Despite the study population size and 24-month median
follow-up period, this study fittingly examines the critical period of
small aneurysm growth between 4.5 and 5.0 cm. Our cohort
accurately recapitulates “real world” surveillance of small aneurysm
patients. Even with 54 patients, we were able to comfortably
demonstrate statistically significant morphologic changes during
small aneurysm growth. However, in spite of these changes, we
were able to also show no statistically significant differences in
endovascular aortic aneurysm repair (EVAR) suitability during
surveillance.
Although it may seem like an apparent contradiction that
observed adverse morphologic changes (shorter and larger aortic
necks) would not lead to decreases in EVAR suitability, closer
examination of the data can explain how these two conclusions can
coexist. The majority of patients who remained EVAR candidates
throughout the study (45 patients, 84%) continued to have long
(15 mm) and suitably narrow (26 mm) infrarenal aortic necks.
Only 16% had borderline aortic neck lengths (10 to 15 mm) and
only 18% had borderline aortic neck diameters (26 to 28 mm).
Therefore, only a minority of patients with small aneurysms are “at
risk” to lose their EVAR suitability during the surveillance period.
This observation suggests that an aneurysm’s suitability for EVAR
is determined early in the morphologic life of the aneurysm—likely
before the maximum aortic diameter reaches 4 cm. If an aneurysm
is not suitable for EVAR when surgical repair is warranted, it is
likely that the aneurysm was unsuitable for EVAR during most of
its natural history. Surveillance likely will exclude very few patients.
Our study also does not support the contention that the
observed morphologic changes will necessarily result in adverse
long-term EVAR outcomes. There is no data that EVAR with
longer aortic necks (26.5 mm at the beginning of the study)
necessarily results in better long-term outcomes than EVAR with
adequately long but shorter necks (20.0 mm at the end of the
study). Surveillance does not change the fact that the majority of
patients suitable for EVAR at the end of surveillance will continue
to have comfortably long and small aortic necks that should not
compromise long-term outcomes with EVAR. Moreover, further
analysis of our data determining EVAR suitability with the poten-
tial use of endografts up to 36 mm in diameter, which only became
recently available in the United States, revealed that EVAR suit-
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ability rates were almost the same during the study period (80% vs
76%; McNemar test, P  .5).
Finally, as level I evidence4 has clearly demonstrated that the
treatment for small abdominal aortic aneurysms (AAA) is unnec-
essary and given that EVAR suitability does not change during
surveillance, as demonstrated in our study, we could not agree
more with Dr Palamara,5 who in a previous letter to the editor of
this journal appropriately expressed that randomized clinical trails
involving EVAR for small AAAs are “neither morally nor scientif-
ically justified”.
Please note a correction in original manuscript. The third
sentence in the last paragraph of the discussion should read: “If an
aneurysm is not suitable for EVAR when surgical repair is war-
ranted, it is likely that the aneurysm was unsuitable for EVAR
during most of its natural history.”
Franklin S. Yau, MD
Baylor Medical Center at Garland
Garland, Tex
Carlos H. Timaran, MD
University of Texas Southwestern Medical Center
Dallas, Tex
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Regarding “Popliteal arterial aneurysm associated
with Klippel-Trénaunay syndrome: Case report and
literature review”
I enjoyed your Case Report of Popliteal Artery Aneurysm on
Klippel-Trénaunay (KTS) patient,1 and also, your reply to the
Letter to the Editor from H. Komai.2 However, there seems to be
unnecessary confusion on the pathogenesis of arterial aneurysm/
arterial dilatation on both reports, which represents “truncular”
form of arterial malformation (AM), although you referred to it
briefly in your report.
AM is one of various congenital vascular malformations
(CVMs)3 and its “truncular lesion” is the result of the develop-
mental arrest in the “latter” stage of embryogenesis. It often
remains along the line of aplasia/hypoplasia/hyperplasia.4
Therefore, it does not possess mesenchymal cell characteristics
of evolutional power to grow; only embryonic tissue remnant from
the “earlier” stage of embryogenesis has, which we call “extratrun-
cular” lesion.
Your observation is typical truncular AM lesion, as you have
already shown in the histology. This truncular lesion lacks suffi-
cient lamellae of smooth muscle cells within the media as its
characteristic. Depending upon the severity, location, and “post-
natal” hemo-arterio-dynamics, this lesion will progress to an aneu-
rysmal condition or stay as “ectatic”condition, which is not un-
common.
Based on this fundamental defect in the arterial wall structure,
it would become more susceptible to pathological change (eg,
atherosclerosis) such as Dr Komai’s case, as you properly specu-
lated in your reply, and the pathogenesis of both cases of the report
is embryonic tissue defect at the latter stage of embryogenesis
resulting in abnormal arterial wall.
Therefore, understanding of embryologic background is war-
ranted for the proper management of this “truncular” form of
arterial malformation.
I also noticed that the “old” name-based nosology/term such
as Klippel Trénaunay Syndrome added more confusion; this old
term failed to fulfill its mandate as a proper classification for various
congenital vascular malformations (CVMs).5
We try to discourage its further use, at least among the
professionals who adopted the Hamburg Classification.6
Any vascular malformation can be involved to KTS but in the
traditional KTS, it generally consists of venous malformation (VM)
and lymphatic malformation (LM) in addition to capillary malfor-
mation (CM) known as “port wine stain”. This “combined form”
of CVM is generally represented by “hemolymphatic” malforma-
tion (HLM) in the new classification.
Occasionally, HLM has additional CVM known as AV mal-
formation (AVM), which condition has been called by a different
name: Parkes Weber Syndrome.
Now, if you should have such AM in addition to all other
CVMs, what is the use for such name-based nosology for the
practical management after all?
I do congratulate you for such an important report, which
would have been a lot better if its embryologic, pathophysiologic,
and hemodynamic backgrounds were included as one of the
CVMs.
Byung-Boong Lee, MD, PhD, FACS
Professor of Surgery & Co-Director, Center for Vein,
Lymphatics, & Vascular Malformation, Georgetown University
School of Medicine, Washington DC
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In his letter to the editor, Professor Lee mentioned that our
observation could correspond with a typical truncular arterial
malformation lesion, which lacked sufficient lamellae of smooth
muscle cells within the media and would progress to an aneurysmal
condition or stay as ecstatic condition, to no small extent, depend-
ing on the severity, location, and postnatal hemo-arterio-dynam-
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